Turmeric compound tested to stop stomach cancer before it starts
NCT ID NCT02782949
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether curcumin, a compound found in turmeric, can prevent stomach cancer in people with chronic atrophic gastritis or gastric intestinal metaplasia. About 50 participants will receive either curcumin or a placebo for a period, and researchers will measure changes in inflammation and cell growth markers. The goal is to see if curcumin can block early changes that lead to cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ATROPHIC GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Regional de Occidente
Santa Rosa de Copán, 41101, Honduras
-
University of Puerto Rico
San Juan, 00936, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a traditional tablet turn back precancerous stomach changes?
- New PET tracer could spot cancers that standard scans overlook
- AI to predict cancer risk from gut bacteria and scans
- New hope for advanced cancer patients as experimental drug enters human testing.
- Personalized blood test aims to track stomach and colon cancer spread